Actively engaged with Terumo in Virtue SAB partnership restructuring discussions.

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies ...

Braun) DEB (based on PACCOCATH® technology [Bayer//Medrad]) compared with the TAXUS Liberté DES for treatment of ISR in native coronary arteries (n = 131 patients, reference diameter 2.5 mm ...

Research Question: Are paclitaxel-coated balloons (PCBs) superior to uncoated balloons (UCBs) in terms of safety and efficacy for the treatment of coronary in-stent restenosis (ISR)? Aims: ...

Among these patients, 56 had stents in the Left Anterior Descending (LAD) artery, while 27 and 34 had stents in the Left Circumflex Artery (LCx) and Right Coronary Artery (RCA), respectively. In total ...

Moreover, according to a study published in the British Journal of Nutrition, those who consume nuts more than four times per week have a 37% lower risk of coronary heart disease. Therefore ...

standing more compared with sitting does not improve cardiovascular health (coronary heart disease, stroke and heart failure), and could increase the ... Which Clot-Busting Drug Is Tied to Better ...

Am J Health Syst Pharm. 2007;64(12):1265-1273.